---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-216388"
form_type: "8-K"
ticker: "VRDN"
cik: "0001590750"
company_name: "Viridian Therapeutics, Inc.\\DE"
filed_at: "2021-07-15T23:59:59+00:00"
generated_at: "2026-06-30T05:07:33.493973+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Viridian appoints Jennifer Moses, CPA to board and as Audit Committee Chair

## Summary
- Appointed Jennifer Moses as Class II director and Chair of Audit Committee, effective July 14, 2021.
- Moses serves as CFO of G1 Therapeutics (GTHX) since 2019; previously partner at Rankin McKenzie.
- Receives $55k annual cash retainer; granted option for 25,000 shares at July 14 closing price, vesting over 3 years.
- CPA with B.S. in Accounting from Penn State; held roles at Deloitte including strategic planning.

## SEC filing metadata
- accession: 0001193125-21-216388
- form_type: 8-K
- ticker: VRDN
- cik: 0001590750
- company_name: Viridian Therapeutics, Inc.\DE
- filed_at: 2021-07-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1590750/000119312521216388/0001193125-21-216388-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1590750/000119312521216388/d200433d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-216388
- JSON: https://secwatch.observer/filing/0001193125-21-216388.json
- Plain text: https://secwatch.observer/filing/0001193125-21-216388.txt

## Key facts
- Executive change
  Jennifer K. Moses was appointed as Director at Viridian Therapeutics, Inc.\DE.
  - Action: appointed
  - Role: Director
  source text: On July 14, 2021, the board of directors (the “Board”) of Viridian Therapeutics, Inc. (the “Company”) appointed Jennifer K. Moses as a member of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1590750/000119312521216388/0001193125-21-216388-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.